Physiologic Regulation of EPO Production for CKD-Anemia: An Opportunity to Enhance Access to Care

Learning Objectives

After completing this activity, the participant should be better able to:

• Describe the personal and societal burden of anemia and its care on patients with CKD, including those undergoing dialysis
• Discuss strategies to enhance access to anemia care for racial groups, such as Black patients, to ensure they receive proper and timely diagnoses and management
• Summarize the role of hypoxia-inducible factor in the production of EPO
• Summarize experience data with hypoxia-inducible factor prolyl hydroxylase inhibitors in increasing Hb levels compared to standard of care in both dialysis-dependent patients and patients not receiving dialysis